Tuesday, April 28, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Review the nonmotor symptoms of PD including psychosis, dementia, anxiety, depression, etc. and discuss their diagnosis and treatment.
Tuesday, May 5, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the diagnosis and initiation of treatment for various commonly seen movement disorders.
Tuesday, May 12, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Evaluate the various treatment options for motor complications in Parkinson’s disease.
Tuesday, May 19, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Explore the role of neurotoxins in treating dystonic symptoms in Parkinson’s disease.
Tuesday, August 18, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the recognition, assessment, and management of PD dementia and psychosis.
Tuesday, August 25, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Review the current treatment options for essential tremor.
Tuesday, September 1, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Evaluate subcutaneous infusion therapies and explore where they fit in the management of PD.
Wednesday, September 9, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Compare and contrast the surgical options for movement disorders
Tuesday, September 15, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Explore the treatment algorithm for treating motor complications in PD.
Tuesday, September 22, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the various formulations of levodopa and their role in the treatment of PD
Tuesday, September 29, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Review case studies highlighting the diagnosis and treatment of common movement disorders.
Tuesday, October 20, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the recognition, diagnosis and treatment of drug induced movement disorders
Tuesday, October 27, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Compare and contrast the various neurotoxins, review how they work and discuss their use in the treatment of movement disorders.
Tuesday, November 3, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Explore the Advances in DBS for PD and other movement disorders
Tuesday, November 17, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Review cases of common non-motor symptoms in PD to improve recognition, diagnosis and treatment of psychosis, dementia, sleep issues, depression and anxiety.
Tuesday, December 1, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the treatment options for PD and review pearls regarding treatment selection
Tuesday, December 8, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Explore various tremor disorders and available treatment options
Tuesday, December 15, 2026
6:30 to 8 pm Central Time
Learning Objective:
· Discuss the 2026 breakthroughs in the diagnosis and management of PD and other movement disorders.
The Kansas City Southwest Clinical Society is accredited by the Oklahoma State Medical Association to provide continuing medical education for physicians. The Kansas City Southwest Clinical Society designates this live activity for a maximum of 32.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.